Position
Chief Regulatory Officer
Company
Diakonos Oncology
HoustonBiotechnologyHealth CareMedicalTherapeuticsDescription
Diakonos Oncology Corporation , a clinical stage immuno-oncology company, announced today that Ian H. Bellayr, Ph.D., a regulatory expert with the U.S. Food and Drug Administration and National Institutes of Health , has joined the company as its Chief Regulatory Officer.
Quick answer
Diakonos Oncology Names Ian H. Bellayr, Ph.D. Chief Regulatory Officer (November 20, 2023). Diakonos Oncology is based in Houston, Texas, United States.
- Who is the new Chief Regulatory Officer at Diakonos Oncology?
- Diakonos Oncology named Ian H. Bellayr Chief Regulatory Officer, announced November 20, 2023.
- What did Diakonos Oncology announce on November 20, 2023?
- Diakonos Oncology Corporation , a clinical stage immuno-oncology company, announced today that Ian H. Bellayr, Ph.D., a regulatory expert with the U.S. Food and Drug Administration and National Institutes of Health , has joined the company as its Chief Regulatory Officer.
- What does Diakonos Oncology do?
- Diakonos Oncology Corp. is a clinical stage immuno-oncology company based in Houston, TX.
- Where is Diakonos Oncology based?
- Diakonos Oncology is based in Houston, Texas, United States.
- Which similar companies made leadership changes around the same time?
- Aethlon Medical (November 13, 2023), Incendia Therapeutics (November 13, 2023), NYU Langone Health (December 1, 2023) and Genentech (November 7, 2023) also announced leadership changes within 45 days of Diakonos Oncology.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (November 13, 2023)
- Incendia Therapeutics Appoints Wendye Robbins, M.D., as Chief Executive Officer and Doses First Patient in Phase 1b Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor (November 13, 2023)
- NYU Langone Hospital--Long Island Appoints Mario E. Lacouture, MD, as the New Chief of Dermatology (December 1, 2023)
- Departure of Alexander Hardy & Appointment of Interim Chief Exec Officer at Genentech (November 7, 2023)
- OncoNano Medicine Announces Promotion of Kartik Krishnan, MD, PhD, to President and Head of Research & Development (November 6, 2023)
- Smart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, strengthening C suite with seasoned oncology expertise (December 4, 2023)
Who to call at Diakonos Oncology, and when
A new leader at Diakonos Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Diakonos Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Diakonos Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Diakonos Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Diakonos Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Diakonos Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.